Applied Clinical Trials November Recap
Our November issue focused on patient centricity with additional coverage around data management.
This November, Applied Clinical Trials focused on the topic of empowering patients. While technology has streamlined many operational aspects of clinical trials, it is also being leveraged to access more potential participants. The November issue of ACT explored some of those innovations and how they are giving more power to patients.
In addition to the current landscape of creating more patient-centric trials, ACT’s November issue focused on electronic methods for capturing clinical data including a use case from a hospital setting.
As we move into the month of December, the following slideshow provides a look back at the previously mentioned topics covered in November.
Image Credit: © Leafart - stock.adobe.com
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
